Kura Oncology Q2 EPS $(0.51) Misses $(0.49) Estimate

Kura Oncology (NASDAQ:KURA) reported quarterly losses of $(0.51) per share which missed the analyst consensus estimate of $(0.49) by 4.08 percent. This is a 27.5 percent decrease over losses of $(0.40) per share from the

Kura Oncology (NASDAQ:KURA) reported quarterly losses of $(0.51) per share which missed the analyst consensus estimate of $(0.49) by 4.08 percent. This is a 27.5 percent decrease over losses of $(0.40) per share from the same period last year.

Total
0
Shares
Related Posts